Cargando…
Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson’s disease patients with penicillamine-induced allergy or early neurological deterioration
The clinical data of safety and efficacy of a combined treatment with dimercaptosuccinic acid (DMSA) and Zinc with 2 years’ follow-up in 60 neurological Wilson’s disease (WD) patients was retrospectively analyzed. All the patients included in the present study were newly diagnosed and initialized wi...
Autores principales: | Zhu, Xiao-Qun, Li, Liang-Yong, Yang, Wen-Ming, Wang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435022/ https://www.ncbi.nlm.nih.gov/pubmed/32809015 http://dx.doi.org/10.1042/BSR20200654 |
Ejemplares similares
-
Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson’s disease
por: Zhang, Jing, et al.
Publicado: (2020) -
Comparison of the Effectiveness and Safety of d-Penicillamine and Zinc Salt Treatment for Symptomatic Wilson Disease: A Systematic Review and Meta‐Analysis
por: Tang, Shan, et al.
Publicado: (2022) -
Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease
por: Ziemssen, Tjalf, et al.
Publicado: (2022) -
Management of Children and Adolescents with Wilson Disease and Neurological Worsening Following D–Penicillamine Therapy: A Single Centre Experience
por: Kumar, Madhan, et al.
Publicado: (2022) -
Early neurological deterioration in Wilson’s disease: a systematic literature review and meta-analysis
por: Antos, Agnieszka, et al.
Publicado: (2023)